Our results showed that MIR452 regulates cell proliferation, cell migration, and angiogenesis by direct suppressing VEGFA expression in early CRC progression; therefore, MIR452 may have therapeutic value in relation to human CRC. The gene discussed is VEGFA; the disease is colorectal carcinoma.